- Home
- GNPX vs DATS Comparison
GNPX vs DATS Comparison
Compare GNPX & DATS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GNPX
- DATS
- Stock Information
- Founded
- GNPX 2009
- DATS 2014
- Country
- GNPX United States
- DATS United States
- Employees
- GNPX N/A
- DATS N/A
- Industry
- GNPX Biotechnology: Pharmaceutical Preparations
- DATS Computer Software: Prepackaged Software
- Sector
- GNPX Health Care
- DATS Technology
- Exchange
- GNPX Nasdaq
- DATS Nasdaq
- Market Cap
- GNPX 6.1M
- DATS 5.2M
- IPO Year
- GNPX 2018
- DATS 2021
- Fundamental
- Price
- GNPX $0.75
- DATS $4.96
- Analyst Decision
- GNPX Strong Buy
- DATS
- Analyst Count
- GNPX 1
- DATS 0
- Target Price
- GNPX $10.00
- DATS N/A
- AVG Volume (30 Days)
- GNPX 367.1K
- DATS 25.0M
- Earning Date
- GNPX 11-13-2024
- DATS 11-14-2024
- Dividend Yield
- GNPX N/A
- DATS N/A
- EPS Growth
- GNPX N/A
- DATS N/A
- EPS
- GNPX N/A
- DATS N/A
- Revenue
- GNPX N/A
- DATS $515.00
- Revenue This Year
- GNPX N/A
- DATS N/A
- Revenue Next Year
- GNPX N/A
- DATS N/A
- P/E Ratio
- GNPX N/A
- DATS N/A
- Revenue Growth
- GNPX N/A
- DATS N/A
- 52 Week Low
- GNPX $0.28
- DATS $1.01
- 52 Week High
- GNPX $13.00
- DATS $9.34
- Technical
- Relative Strength Index (RSI)
- GNPX 40.74
- DATS 56.07
- Support Level
- GNPX $0.66
- DATS $4.30
- Resistance Level
- GNPX $0.74
- DATS $7.18
- Average True Range (ATR)
- GNPX 0.06
- DATS 1.65
- MACD
- GNPX 0.00
- DATS 0.11
- Stochastic Oscillator
- GNPX 35.04
- DATS 42.29
About GNPX Genprex Inc.
Genprex Inc is a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes. Its technologies are designed to administer disease-fighting genes to provide new therapies for large patient populations with cancer and diabetes who currently have limited treatment options. Genprex's oncology program utilizes its systemic, non-viral Oncoprex Delivery System which encapsulates the gene-expressing plasmids using lipid-based nanoparticles in a lipoplex form. The company's lead product candidate, Reqorsa Immunogene Therapy (quaratusugene ozeplasmid), is being evaluated in three clinical trials as a treatment for NSCLC and SCLC.
About DATS DatChat Inc.
DatChat Inc is a blockchain, cybersecurity, and social media company that not only focuses on protecting privacy on personal devices, but also protects user information after it is shared with others. Its mobile messaging application is called DatChat Messenger which is a free messaging application. The platform allows users to exercise control over their messages and posts, even after they are sent.